EMA Extends Benefits Of Reduced Parallel Distribution Fee To Estonia, Slovenia
Executive Summary
Estonia and Slovenia have been accepted onto an ongoing initiative by the European Medicines Agency that aims to boost the availability of centrally authorized drugs in smaller member states by charging companies a reduced fee for parallel distribution of medicines.